Cat. No. | Product Name / Activity |
---|---|
6764 | B 973B |
Positive allosteric modulator of α7 nAChRs; analgesic | |
6009 | B I09 |
IRE1 endonuclease inhibitor; cell permeable | |
1802 | 2B-(SP) |
Selective GSK-3 phosphopeptide substrate | |
2759 | B-HT 920 |
D2 agonist; also α2-adrenoceptor agonist and 5-HT3 antagonist | |
2758 | B-HT 933 dihydrochloride |
Selective α2 agonist | |
6392 | B02 |
RAD51 recombinase inhibitor | |
2855 | B2 |
Promotes inclusion formation in Huntington's and Parkinson's diseases | |
5600 | BA 1 |
Potent bombesin agonist | |
1326 | BADGE |
PPARγ antagonist | |
3606 | BAG 956 |
Dual PI 3-kinase and PDPK1 (PDK1) inhibitor | |
1763 | BAM (8-22) |
Potent MRGPRX1 agonist | |
5737 | BAM 15 |
Mitochondrial protonophore uncoupler | |
1650 | BAM 22P |
MRGPRX1 agonist; also opioid receptor agonist | |
4810 | BAM 7 |
Selective Bax activator; induces Bax-mediated apoptosis | |
2786 | BAPTA |
Selective calcium chelator | |
2787 | BAPTA AM |
Cell-permeable Ca2+ chelator | |
6857 | BAY 293 |
Potent KRas/SOS1 interaction inhibitor | |
6906 | BAY 293 Negative Control |
Negative control for BAY 293 (Cat. No. 6857) | |
5970 | BAY 299 |
Potent and selective BRD1 and TAF1 inhibitor | |
4430 | BAY 41-2272 |
Soluble guanylyl cyclase (sGC) activator | |
5708 | BAY 41-8543 |
Guanylyl cyclase (sGC) stimulator | |
6052 | BAY 58-2667 hydrochloride |
Potent soluble guanylyl cyclase (sGC) activator | |
5991 | BAY 598 |
Potent and selective SMYD2 inhibitor | |
4472 | BAY 60-6583 |
Potent A2B agonist; cardioprotective | |
6561 | BAY 6035 |
Potent and selective SMYD3 inhibitor | |
6389 | BAY 677 |
Inactive control for BAY 678 (Cat.No.5706) | |
5706 | BAY 678 |
Potent and selective cell-permeable human neutrophil elastase (HNE) inhibitor | |
6562 | BAY 707 New |
Potent and selective MTH1 inhibitor | |
6817 | BAY 8002 |
Potent dual MCT1/2 inhibitor; orally bioavailable | |
6579 | BAY 826 |
Potent Tie2 inhibitor | |
6980 | BAY 87-2243 |
Mitochondrial complex I inhibitor | |
6199 | BAY 876 |
Potent and selective GLUT1 inhibitor | |
3541 | BAY-X 1005 |
Orally active 5-lipoxygenase activating protein (FLAP) inhibitor | |
2732 | BAY-u 3405 |
Dual TP/DP2 (CRTH2) receptor antagonist | |
5266 | BAZ2-ICR |
Selective BAZ2 inhibitor | |
4372 | BC 11 hydrobromide |
Selective urokinase (uPA) inhibitor | |
4496 | BC 11-38 |
Selective PDE11 inhibitor | |
6791 | BC-LI-0186 |
Leucyl-tRNA synthase (TRS)/Ras-related GTP-binding protein D (RagD) interaction inhibitor | |
5027 | BCH |
LAT1 inhibitor | |
3875 | BCTC |
TRPV1 antagonist | |
0956 | BD 1047 dihydrobromide |
σ1 selective antagonist | |
0883 | BD 1063 dihydrochloride |
Selective σ1 ligand, putative antagonist | |
3579 | 5-BDBD |
Potent and selective P2X4 antagonist | |
2837 | BDNF (human) |
Activates TrkB and p75 receptors | |
5184 | BDS I |
Potent and reversible Kv3.4 potassium channel blocker; neuroprotective | |
5468 | BDY 630-X, SE |
Red BDY (BODIPY® or boron-dipyrromethene) fluorescent dye for the labeling of amines; supplied as NHS ester | |
5469 | BDY 650-X, SE |
Far-red BDY (BODIPY® or boron-dipyrromethene) fluorescent dye for the labeling of amines; supplied as NHS ester | |
5465 | BDY FL, SE |
Green BDY (BODIPY® or boron-dipyrromethene) fluorescent dye for the labeling of amines; supplied as NHS ester | |
5620 | BDY FL-X, SE |
Green BDY (BODIPY® or boron-dipyrromethene) fluorescent dye for the labeling of amines; supplied as NHS ester | |
5466 | BDY TMR-X, SE |
Yellow BDY (BODIPY® or boron-dipyrromethene) fluorescent dye for the labeling of amines; supplied as NHS ester | |
5467 | BDY TR-X, SE |
Orange/red BDY (BODIPY® or boron-dipyrromethene) fluorescent dye for the labeling of amines; supplied as NHS ester | |
4778 | BETP |
Positive allosteric modulator of GLP-1 receptors | |
3743 | BF 2649 hydrochloride |
Potent and selective H3 inverse agonist | |
6246 | BF 738735 |
Potent and selective PI 4-kinase IIIβ inhibitor; broad spectrum enterovirus replication inhibitor | |
0348 | 2-BFI hydrochloride |
Potent, selective I2 ligand. Putative agonist | |
5327 | BGC 20-1531 hydrochloride |
High affinity and selective EP4 antagonist | |
3326 | BGC 20-761 |
High affinity 5-HT6 antagonist | |
6703 | BGP 15 |
PARP inhibitor; cytoprotectant | |
3313 | rac BHFF |
Potent and selective postitive allosteric modulator of GABAB receptors | |
6116 | BHPI |
ERα antagonist; also activates unfolded protein response; active in vivo | |
1236 | BHQ |
Inhibitor of SERCA ATPase | |
6518 | BI 01383298 |
Potent and selective SLC13A5 (Na+/citrate cotransporter) inhibitor | |
4641 | BI 6015 |
Hepatocyte nuclear factor 4α (HNF4α) antagonist | |
5300 | BI 605906 |
Selective IKKβ inhibitor | |
3314 | BI 78D3 |
Selective, competitive JNK inhibitor | |
6665 | BI 9321 |
Nuclear receptor-binding SET domain (NSD) 3 antagonist; selectively binds PWWP1 domain | |
5590 | BI 9564 |
Potent and selective BRD9 and BRD7 inhibitor; orally active | |
4561 | BIBN 4096 |
Potent and selective CGRP antagonist | |
2412 | BIBO 3304 trifluoroacetate |
Highly selective NPY Y1 receptor antagonist | |
2707 | BIBP 3226 trifluoroacetate |
Mixed NPY Y1 and NPFF receptor antagonist | |
2981 | BIBR 1532 |
Selective telomerase inhibitor | |
2417 | BIBU 1361 dihydrochloride |
Selective inhibitor of EGFR-kinase | |
2416 | BIBX 1382 dihydrochloride |
Highly selective EGFR-kinase inhibitor | |
4608 | BIIB 021 |
Selective Hsp90 inhibitor | |
7377 | BIIE 0246 hydrochloride New |
Potent, selective and competitive non-peptide NPY Y2 receptor antagonist; active in vivo | |
2716 | BIM 187 |
Bombesin/GRP receptor agonist | |
2717 | BIM 189 |
Bombesin antagonist | |
3237 | BIM 23042 |
Selective neuromedin B receptor antagonist (NMB-R, BB1) | |
1844 | BIM 23056 |
sst ligand | |
4374 | BIMU 8 |
Potent 5-HT4 agonist | |
4048 | BINA |
Selective positive allosteric modulator of mGlu2 receptors | |
3194 | BIO |
Potent GSK-3 inhibitor; also inhibits cdks | |
3910 | BIO 1211 |
Selective α4β1 (VLA-4) inhibitor | |
5051 | BIO 5192 |
Highly potent and selective inhibitor of integrin α4β1 (VLA-4) | |
3874 | BIO-acetoxime |
Selective GSK-3α/β inhibitor | |
5989 | BIRB 796 |
High affinity and selective p38 kinase inhibitor | |
4776 | BIRT 377 |
Potent negative allosteric modulator of LFA-1 | |
5216 | BIS-TRIS |
Commonly used Zwitterionic buffer | |
5375 | BIX |
BiP (Hsp70-5) ER chaperone inducer | |
3364 | BIX 01294 |
GLP and G9a inhibitor | |
4842 | BIX 02189 |
Selective MEK5 and ERK5 inhibitor | |
5512 | BIX NHE1 inhibitor |
Potent and selective NHE1 inhibitor | |
3797 | BL 1249 |
K2P2.1 (TREK-1) and K2P10.1 (TREK-2) activator | |
2538 | L-BMAA hydrochloride |
Neurotoxic amino acid | |
5417 | BMH 21 |
RNA polymerase I inhibitor; also p53 pathway activator | |
5488 | BML 111 |
FPR2 (lipoxin A4 receptor) agonist | |
1441 | BMS 182874 hydrochloride |
Highly selective, orally active non-peptide ETA antagonist | |
2665 | BMS 191011 |
Potent KCa1.1 (BK) channel opener | |
3242 | BMS 193885 |
Potent, competitive NPY Y1 receptor antagonist | |
3660 | BMS 195614 |
Selective RARα antagonist | |
5654 | BMS 265246 |
Cdk inhibitor; potently inhibits cdk1 and cdk2 | |
2870 | BMS 299897 |
Potent γ-secretase inhibitor | |
4609 | BMS 303141 |
ATP citrate lyase inhibitor; orally bioavailable | |
5258 | BMS 309403 |
Potent and selective FABP4 inhibitor | |
4806 | BMS 345541 |
Selective allosteric inhibitor of IKK; anti-inflammatory | |
3409 | BMS 453 |
Synthetic retinoid and RARβ agonist; also RARα and RARγ antagonist | |
4053 | BMS 470539 dihydrochloride |
Potent, selective MC1 receptor agonist | |
3509 | BMS 493 |
Pan-RAR inverse agonist | |
5009 | BMS 509744 |
Potent and selective ITK inhibitor | |
4774 | BMS 536924 |
Dual IR/IGF1R inhibitor | |
5274 | BMS 564929 |
Highly potent and muscle-selective androgen receptor (AR) agonist | |
5492 | BMS 566419 |
Inosine monophosphatase dehydrogenase (IMPDH) inhibitor | |
5022 | BMS 599626 dihydrochloride |
Potent, selective EGFR and ErbB2 inhibitor | |
6069 | BMS 605541 |
Potent VEGFR-2 inhibitor | |
4970 | BMS 688521 |
Potent inhibitor of the LFA-1/ICAM interaction | |
3505 | BMS 753 |
RARα-selective agonist | |
5762 | BMS 795311 |
Potent cholesteryl ester transfer protein (CETP) inhibitor | |
3410 | BMS 961 |
Selective RARγ agonist | |
6974 | BMS 986094 |
Inhibitor of HCV RNA-dependent RNA polymerase (RdRP; NS5b); potent hepatitis C virus (HCV) replication inhibitor | |
5983 | BMS 986187 |
Potent positive allosteric modulator of δ receptors | |
3129 | BMS CCR2 22 |
High affinity, potent CCR2 antagonist | |
5123 | BMX-IN-1 |
Potent and irreversible BMX inhibitor | |
1440 | BMY 14802 hydrochloride |
Sigma antagonist. Antipsychotic agent | |
1442 | BMY 45778 |
Non-prostanoid prostacyclin IP receptor partial agonist | |
1006 | BMY 7378 dihydrochloride |
Selective α1D antagonist | |
0899 | BNTX maleate |
Standard δ1 selective antagonist | |
6047 | BOP |
Dual α9β1/α4β1 integrin inhibitor; preferentially mobilizes HSCs | |
6996 | BOP-JF549 New |
Yellow fluorescent dual α9β1/α4β1 integrin inhibitor comprising BOP conjugated to Janelia Fluor® 549; fluorogenic; photostable | |
6997 | BOP-JF646 New |
Red fluorescent dual α9β1/α4β1 integrin inhibitor comprising BOP conjugated to Janelia Fluor® 646; fluorogenic; photostable | |
0556 | BP 554 maleate |
Selective 5-HT1A agonist | |
5301 | BPTES |
Selective allosteric glutaminase (GLS1) inhibitor | |
6078 | BPTU |
P2Y1 allosteric antagonist | |
1500 | BQ 788 sodium salt |
Selective ETB antagonist | |
1188 | BQ-123 |
Selective ETA antagonist | |
1189 | BQ-3020 |
Selective ETB agonist | |
6872 | BQCA |
Positive allosteric modulator of M1 receptors | |
5312 | BRACO 19 trihydrochloride |
Telomerase inhibitor | |
6010 | BRD 4354 |
HDAC5 and HDAC9 inhibitor | |
6282 | BRD 4770 |
G9a inhibitor and S-adenosyl methionine mimetic; cell permeable | |
6438 | BRD 6989 |
Cdk8 inhibitor; enhances IL-10 production | |
4037 | BRD 7389 |
Ribosomal S6 kinase inhibitor | |
6284 | BRD 73954 |
Dual histone deacetylase (HDAC) 6/8 inhibitor | |
5230 | BRD 7552 |
PDX1 transcription factor inducer; increases insulin expression | |
6040 | BRD 9757 |
Potent and selective HDAC6 inhibitor | |
1207 | BRL 15572 hydrochloride |
Selective h5-HT1D antagonist | |
0948 | BRL 37344, sodium salt |
β3 agonist | |
1133 | BRL 44408 maleate |
Selective α2A antagonist | |
2237 | BRL 50481 |
Selective PDE7 inhibitor | |
0699 | BRL 52537 hydrochloride |
Potent and selective κ agonist | |
1129 | BRL 54443 |
Potent 5-ht1E and 5-HT1F agonist | |
5608 | BS 181 dihydrochloride |
Selective cdk7 inhibitor | |
5817 | BSI 201 |
PARP-1 inhibitor | |
6921 | BSJ-03-123 |
Selective Cdk6 degrader | |
6938 | BSJ-03-204 |
Selective Cdk4/6 degrader | |
6937 | BSJ-04-132 |
Selective Cdk4 degrader | |
6922 | BSJ-Bump |
Negative control for BSJ-03-123 (Cat. No. 6921) | |
5399 | BTB1 |
Selective and ATP-competitive Kif18A inhibitor | |
6940 | BTD |
Selective TRPC5 activator | |
1870 | BTS |
Selective inhibitor of skeletal muscle myosin II ATPase activity | |
2322 | BTS 54-505 hydrochloride |
Potent 5-HT and NA reuptake inhibitor (SNRI); active metabolite of sibutramine (Cat. No. 2290) | |
4724 | BTT 3033 |
Selective inhibitor of integrin α2β1 | |
4204 | BTZO 1 |
MIF binder | |
0725 | BU 224 hydrochloride |
Potent, selective I2 ligand. Putative antagonist | |
1091 | BU 226 hydrochloride |
Potent, highly selective I2 ligand | |
0726 | BU 239 hydrochloride |
Potent, highly selective I2 ligand | |
2176 | BVT 948 |
Non-competitive protein tyrosine phosphatase inhibitor | |
1663 | BW 373U86 |
Potent, selective non-peptide δ agonist | |
1059 | BW 723C86 hydrochloride |
5-HT2B agonist | |
1304 | BW-B 70C |
5-Lipoxygenase inhibitor | |
5545 | BX 430 |
Selective P2X4 allosteric antagonist | |
3496 | BX 471 |
Potent, selective CCR1 antagonist | |
2769 | BX 513 hydrochloride |
Selective CCR1 antagonist | |
4318 | BX 795 |
PDPK1 (PDK1) inhibitor | |
2866 | BYK 191023 dihydrochloride |
Potent and selective inhibitor of iNOS | |
3735 | BYK 49187 |
PARP-1 and PARP-2 inhibitor | |
0796 | (R)-Baclofen |
Selective GABAB agonist; active enantiomer of (RS)-Baclofen (Cat. No. 0417) | |
0417 | (RS)-Baclofen |
Selective GABAB agonist | |
1334 | Bafilomycin A1 |
H+-ATPase (vacuolar) inhibitor | |
1761 | Baicalein |
5- and 12-Lipoxygenase inhibitor | |
5585 | Balicatib |
Potent and selective cathepsin K inhibitor | |
4219 | Banoxantrone dihydrochloride |
Prodrug topoisomerase II inhibitor | |
7222 | Baricitinib |
Highly potent JAK1 and JAK2 inhibitor; also inhibits JAK3 and Tyk2 | |
2961 | Batimastat |
Potent, broad spectrum MMP inhibitor | |
2160 | Bax channel blocker |
Allosteric inhibitor of Bax channel activation | |
1785 | Bax inhibitor peptide V5 |
Inhibitor of Bax-mediated apoptosis | |
1743 | Bay 11-7085 |
Irreversible inhibitor of TNF-α-induced IκBα phosphorylation | |
1744 | Bay 11-7821 |
E2 ubiquitin (Ub) conjugating enzymes inhibitor | |
2501 | Bay 36-7620 |
mGlu1 inverse agonist | |
2711 | Bay 55-9837 |
Potent and selective VPAC2 agonist | |
2500 | Bay 59-3074 |
CB1/CB2 receptor partial agonist | |
1544 | (±)-Bay K 8644 |
CaV1.x activator | |
1545 | (R)-(+)-Bay K 8644 |
CaV1.x blocker; (R)-(+)-enantiomer of (±)-Bay K 8644; also TMEM176B inhibitor | |
1546 | (S)-(-)-Bay K 8644 |
CaV1.x activator; (S)-(-)-enantiomer of (±)-Bay K 8644 | |
5263 | Bazedoxifene acetate |
Potent and selective estrogen receptor modulator (SERM) | |
5929 | BeKm 1 |
Potent and selective KV11.1 (hERG) channel blocker | |
4283 | Begacestat |
γ-secretase inhibitor; lowers Aβ40 and Aβ42 levels | |
2578 | Benazepril hydrochloride |
Angiotensin-converting enzyme (ACE) inhibitor | |
3681 | Bendamustine hydrochloride |
Cytostatic agent; exhibits DNA alkylating and purine analog properties | |
5273 | Bengamide B |
Potent inhibitor of NF-κB activation | |
3380 | Benzamil |
NCX inhibitor, Deg/ENaC channel blocker; amiloride (Cat. No. 0890) derivative | |
0424 | Benzoquinonium dibromide |
nAChR antagonist | |
0754 | N-Benzylnaltrindole hydrochloride |
Selective non-peptide δ2 antagonist | |
4117 | Bepridil hydrochloride |
Non-selective Ca2+ channel blocker; also NCX inhibitor | |
4180 | Beraprost sodium |
Potent prostacyclin IP receptor agonist | |
1956 | Bestatin |
Aminopeptidase inhibitor | |
0906 | Betaxolol hydrochloride |
Selective β1 antagonist | |
3906 | Betulinic acid |
Antitumor and anti-HIV agent; activates NF-κB. Also TGR5 agonist | |
5819 | Bexarotene |
Potent and selective RXR agonist | |
3389 | Bicalutamide |
Non-steroidal androgen receptor antagonist | |
4357 | Bicifadine hydrochloride |
Noradrenalin, 5-HT and dopamine re-uptake inhibitor | |
5881 | Bicine |
General purpose buffer | |
2503 | (-)-Bicuculline methiodide |
GABAA antagonist; more water soluble version of (+)-bicuculline (Cat. No. 0130) | |
0109 | (-)-Bicuculline methobromide |
GABAA antagonist; more water soluble version of (+)-bicuculline (Cat. No. 0130) | |
0131 | (-)-Bicuculline methochloride |
GABAA antagonist; more water soluble version of (+)-bicuculline (Cat. No. 0130) | |
0130 | (+)-Bicuculline |
Potent GABAA antagonist | |
0767 | Bifemelane hydrochloride |
Non-selective MAO inhibitor | |
6304 | BigLEN (mouse) |
GPR171 agonist | |
0347 | nor-Binaltorphimine dihydrochloride |
Selective κ antagonist | |
3349 | Biocytin |
Versatile marker for neuroanatomical investigations | |
3526 | BIM, Biotinylated |
Bim peptide fragment | |
6571 | Biotin-11-dUTP |
Biotin-labeled dUTP | |
6572 | Biotin-LC-NAD+ |
Biotinylated analog of β-NAD+; commonly used reagent in LSD1 and PARP1 assays | |
6573 | Biotin-NAD+ |
Biotinylated-NAD+; substrate for ADP-ribosylation | |
6241 | Biotinyl Tyramide |
Reagent widely used for signal amplification in IHC and FISH | |
5372 | Bioymifi |
DR5 (TRAIL receptor) agonist; induces apoptosis | |
2853 | Biperiden hydrochloride |
Muscarinic receptor antagonist; some selectivity for M1 | |
5348 | 6,8-Bis(benzylthio)octanoic acid |
PDH and KGDH inhibitor | |
0918 | 3α-Bis-(4-fluorophenyl) methoxytropane hydrochloride |
Potent dopamine uptake inhibitor | |
4128 | Bisindolylmaleimide II |
Potent PKC inhibitor; also potent nAChR antagonist | |
5502 | Blasticidin S HCl |
Antibiotic; selection reagent for bis, bsr and BSD transformed cells | |
1853 | (R)-(+)-Blebbistatin |
Selective inhibitor of myosin II ATPase activity. Inactive enantiomer of (±)-blebbistatin (Cat. No. 1760) | |
1852 | (S)-(-)-Blebbistatin |
Selective inhibitor of myosin II ATPase activity. Active enantiomer of (±)-blebbistatin (Cat. No. 1760) | |
1760 | (±)-Blebbistatin |
Selective inhibitor of myosin II ATPase activity | |
5255 | 6-Bnz-cAMP sodium salt |
Cell permeable cAMP analog | |
3730 | Boc-MLF |
FPR1 antagonist | |
1149 | Bombesin |
Involved in gastrointestinal tract function | |
3422 | [D-Phe12,Leu14]-Bombesin |
Bombesin receptor antagonist | |
2371 | Bombinakinin M |
Potent bradykinin agonist | |
2370 | Bombinakinin-GAP |
Bioactive, bradykinin-related peptide | |
4706 | Borrelidin |
Antiangiogenic; inhibits threonyl-tRNA synthetase | |
7282 | Bortezomib New |
High affinity proteasome inhibitor | |
6232 | Bosentan |
High affinity dual ETA and ETB receptor antagonist;orally bioavailable | |
4361 | Bosutinib |
Dual Src-Abl inhibitor; antiproliferative | |
5217 | Bovine Serum Albumin |
BSA (bovine serum albumin) is a blocking buffer for IHC, ICC, ELISA and Western blotting; used to block non-specific antibody binding. Commonly used in cell culture | |
3004 | Bradykinin |
Endogenous agonist at bradykinin receptors (B2 > B1) | |
3230 | Sar-[D-Phe8]-des-Arg9-Bradykinin |
Potent and selective B1 agonist | |
3225 | Lys-[Des-Arg9]Bradykinin |
Selective B1 agonist | |
3229 | [Phe8Ψ(CH-NH)-Arg9]-Bradykinin |
Selective B2 agonist | |
3522 | Brain natriuretic peptide (1-32) (human) |
Endogenous peptide agonist at ANP receptor A (NPR1) | |
1231 | Brefeldin A |
Disrupts protein translocation to Golgi | |
6196 | Brequinar sodium |
Potent and selective DHODH inhibitor | |
3568 | Bretazenil |
Benzodiazepine partial agonist | |
1140 | 8-Bromo-cAMP, sodium salt |
Cell-permeable cAMP analog | |
1089 | 8-Bromo-cGMP, sodium salt |
cGMP analog; activates PKG | |
0427 | Bromocriptine mesylate |
D2-like agonist (D2>D3>D4) | |
3549 | 3-Bromocytisine |
Potent α4β4, α4β2 and α7 nAChR agonist | |
5015 | 5-BrdU |
Synthetic thymidine analog; used for cell proliferation assays | |
0735 | 3-Bromo-7-nitroindazole |
Selective nNOS inhibitor | |
5218 | Bromophenol Blue |
Dye used in gel loading buffers | |
4758 | Bromosporine |
Broad spectrum bromodomain inhibitor | |
4316 | Bropirimine |
Immunomodulatory and antitumor compound | |
2383 | Bryostatin 1 |
Protein kinase C activator | |
5238 | Bryostatin 3 |
Potent protein kinase C activator | |
2671 | Budesonide |
Synthetic glucocorticoid; anti-inflammatory and chemopreventive | |
3108 | Bumetanide |
Na+/2Cl-/K+ (NKCC) symporter inhibitor | |
2133 | α-Bungarotoxin |
Selective α7 nAChR antagonist | |
2808 | Buprenorphine hydrochloride |
NOP agonist; also displays mixed action δ, κ and μ receptors | |
2831 | Bupropion hydrochloride |
Non-selective inhibitor of dopamine and noradrenalin transporters | |
0962 | Buspirone hydrochloride |
5-HT1A partial agonist | |
1323 | Butabindide oxalate |
High affinity CCK-inactivating serine protease inhibitor | |
5791 | Bz 423 |
ATP synthase inhibitor; proapoptotic | |
3312 | BzATP triethylammonium salt |
Photoaffinity label for ATPase; also P2X7 agonist and P2X1/P2Y1 partial agonist | |
6786 | BzF |
Photoreactive unnatural amino acid; photo-crosslinker |